Early Identification of Chronic Lung Allograft Dysfunction: The Need of Biomarkers
A growing number of patients with end-stage lung disease have benefited from lung transplantation (LT). Improvements in organ procurement, surgical techniques and intensive care management have greatly increased short-term graft survival. However, long-term outcomes remain limited, mainly due to the...
Main Authors: | Adrien Tissot, Richard Danger, Johanna Claustre, Antoine Magnan, Sophie Brouard |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2019-07-01
|
Series: | Frontiers in Immunology |
Subjects: | |
Online Access: | https://www.frontiersin.org/article/10.3389/fimmu.2019.01681/full |
Similar Items
-
Systems prediction of chronic lung allograft dysfunction: Results and perspectives from the Cohort of Lung Transplantation and Systems prediction of Chronic Lung Allograft Dysfunction cohorts
by: Christophe Pison, et al.
Published: (2023-03-01) -
Activation of Humoral Immunity during the Pathogenesis of Experimental Chronic Lung Allograft Dysfunction
by: Martin Reichert, et al.
Published: (2022-07-01) -
Changes in HCMV immune cell frequency and phenotype are associated with chronic lung allograft dysfunction
by: Amélie Rousselière, et al.
Published: (2023-04-01) -
Cessation of extracorporeal photopheresis in chronic lung allograft dysfunction: effects on clinical outcome in adults
by: Cécile Robinson, et al.
Published: (2017-03-01) -
Metformin attenuates chronic lung allograft dysfunction: evidence in rat models
by: Dong Tian, et al.
Published: (2023-07-01)